highly significantp = 0.0009
The odds ratio (OR) for developing symptomatic brain metastasis in the HER2-positive versus HER2-negative population was highly significant at 8.26 (95%CI 2.09–35.60; p = 0.0009).
The odds ratio (OR) for developing symptomatic brain metastasis in the HER2-positive versus HER2-negative population was highly significant at 8.26 (95%CI 2.09–35.60; p = 0.0009).